Neurobiological Technologies, Inc.

is a biotechnology company engaged in the business of acquiring and developing central nervous system (CNS) related drug candidates.

Corporate Spotlight

May 08, 2008
Neurobiological Technologies Sets Date for Third Quarter Financial Results 

April 30, 2008
Neurobiological Technologies Reports Receipt of $2.0 Million Royalty Payment for Quarterly Sales of Memantine 

NASDAQ:: NTII
     

Clinical Trials

XERECEPT® Phase III Trials for the Treatment of Peritumoral Brain Edema

Viprinex Phase III Trials for the Treatment of Acute Ischemic Stroke

View Clinical Trial Educational Film Trailer
(5 minutes)


About NTIProductsPipelineInvestorsNews & InformationContact Us
Change Font Size:                  Print This Page: 
Home | Site Map | Glossary |  Search      
© 2006 Neurobiological Technologies, Inc.built@zoomedia.com